🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Guangzhou 8th People's Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with Guangzhou 8th People's Hospital as lead sponsor. Synced 27 Sep 2026
9Current trials
9Recruiting now
3Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Guangzhou 8th People's Hospital is the lead sponsor of 9 current clinical trials in our China register. 9 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Gammora, LPV/r and Peginterferon alfa-2b. The most-studied condition is AIDS.

ClinicalTrials.gov trials by status

  • Recruiting9100%

Trials by phase

  • Observational778%
  • Phase 1111%
  • Not applicable111%
01

Clinical trials sponsored by Guangzhou 8th People's Hospital

9 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients
NCT05988879 · ClinicalTrials.gov ↗ · AIDS, Hepatitis B
Observational Recruiting 2023-08 China
Risk Identification Factors for Pulmonary Function Impairment in AIDS Patients Recovered From Severe Pneumonia
NCT06137196 · ClinicalTrials.gov ↗ · AIDS, Pneumonia
Observational Recruiting 2023-11 China
Simplified Treatment of Anti-retrovirus in China (C-STAR)
NCT03603977 · ClinicalTrials.gov ↗ · HIV/AIDS
Drugs: Gammora, LPV/r
Observational Recruiting 2017-11 China
Metagenomic Next-Generation Sequencing Guides Anti-Infection Strategies
NCT06145841 · ClinicalTrials.gov ↗ · AIDS, Pneumonia, Sepsis, Neonatal
Observational Recruiting 2023-10 China
The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function
NCT03240328 · ClinicalTrials.gov ↗ · HIV/AIDS
Phase 1 Recruiting 2017-10 China
Comparison of TAF and TDF in Preventing Mother-to-Child Transmission of HBV in Pregnancies With High Viral Loads
NCT06947356 · ClinicalTrials.gov ↗ · Hepatitis B
Not applicable Recruiting 2025-05 China
Observational Study on Patients With HIV/AIDS(OSPWH)
NCT04667026 · ClinicalTrials.gov ↗ · HIV Infections
Observational Recruiting 2009-01 China
Dolutegravir Plus Lamivudine Simplified Therapy
NCT03884673 · ClinicalTrials.gov ↗ · HIV/AIDS
Drug: Gammora
Observational Recruiting 2019-01 China
Clinical Application of Cytokine Adsorption Technique in AIDS Patients With Severe Pneumonia and/or Septic Shock
NCT06145828 · ClinicalTrials.gov ↗ · AIDS Pneumonia, Septic Shock
Observational Recruiting 2023-10 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Guangzhou 8th People's Hospital trials

3 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Guangzhou 8th People's Hospital trials

8 conditions
AIDS3HIV/AIDS3Hepatitis B2Pneumonia2Sepsis, Neonatal1HIV Infections1AIDS Pneumonia1Septic Shock1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China99

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in AIDS

SponsorTrials
Shanghai Public Health Clinical Center1

Sponsors with the most current trials registered for this condition.

06

Questions about Guangzhou 8th People's Hospital trials

How many clinical trials does Guangzhou 8th People's Hospital sponsor?

Guangzhou 8th People's Hospital is the lead sponsor of 9 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.

Are Guangzhou 8th People's Hospital trials recruiting?

Yes. 9 of its 9 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Guangzhou 8th People's Hospital testing?

Its current trials name 3 drugs and biologicals as interventions. The most frequent are Gammora (2), LPV/r (1) and Peginterferon alfa-2b (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.